Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies]
Verena Keitel1, Stephan Vom Dahl1, Dieter Häussinger1
1Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf.
Abstract:
Secondary causes of fatty liver disease are important to recognize since specific therapy options are available for some of these causes. Common causes of secondary fatty liver disease comprise hepatitis C virus infection (HCV), endocrinological diseases, nutritional and intestinal diseases as well as genetic liver and metabolic diseases. Certain drugs may also predispose to the development of fatty liver disease. Primary fatty liver disease, also known as non-alcoholic fatty liver disease (NAFLD) is defined by the presence of steatosis hepatis without relevant alcohol consumption or other causes of secondary fatty liver disease. NAFLD occurs more frequently in patients with metabolic syndrome and thus can be seen as the hepatic manifestation of the metabolic syndrome.Therefore, presence of features of the metabolic syndrome should be assessed in all patients with fatty liver disease. Furthermore, alcohol consumption should be determined to rule out alcoholic liver disease (ASH). Further diagnostic work up for secondary causes of fatty liver disease should include screening for HCV infection, for hypothyroidism and for drugs associated with steatosis development. In a next step screening for Wilson's disease, hemochromatosis, celiac disease and lipid metabolism disorders should be performed. An extended endocrinological workup and a liver biopsy should be considered if the etiology of fatty liver disease remains unclear.Common genetic polymorphisms have been identified in several genes, such as PNPLA3, TM6SF2 and MBOAT7, which may promote the development and the progression of fatty liver disease irrespective of the underlying etiology (e. g. metabolic syndrome, ASH or HCV). The risk variants in these genes have additive effects on steatosis development and diseases progression towards fibrosis and cirrhosis. The diagnosis of secondary causes of fatty liver disease may allow for therapeutic intervention and prevent disease progression. Accordingly, secondary causes of fatty liver disease should be considered during the diagnostic workup of NAFLD patients.
Insights
Recognizing secondary causes of fatty liver disease, like viral infections or metabolic disorders, is crucial for targeted treatment and preventing progression. Early diagnosis of these underlying conditions improves patient outcomes in fatty liver disease management.
Area of Science:
- Hepatology
- Internal Medicine
- Genetics
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome.
- Secondary causes of fatty liver disease require specific therapies and are often linked to infections, endocrine disorders, or genetic factors.
- Genetic polymorphisms in PNPLA3, TM6SF2, and MBOAT7 influence fatty liver disease development and progression.
Purpose of the Study:
- To emphasize the importance of identifying secondary causes of fatty liver disease.
- To outline diagnostic strategies for differentiating NAFLD from secondary etiologies.
- To highlight the role of genetic factors in fatty liver disease pathogenesis.
Main Methods:
- Assessment of metabolic syndrome features and alcohol consumption.
- Screening for hepatitis C virus (HCV) infection, hypothyroidism, and drug-induced steatosis.
- Evaluation for genetic disorders like Wilson's disease, hemochromatosis, celiac disease, and lipid metabolism disorders.
- Consideration of extended endocrinological workup and liver biopsy when etiology remains unclear.
Main Results:
- Secondary causes, including HCV, endocrine diseases, nutritional issues, and genetic factors, contribute significantly to fatty liver disease.
- Metabolic syndrome is frequently associated with NAFLD.
- Specific genetic variants can exacerbate steatosis and disease progression.
Conclusions:
- Diagnosing secondary causes of fatty liver disease enables targeted therapeutic interventions.
- Comprehensive workup, including genetic screening, is essential for managing fatty liver disease effectively.
- Early identification and treatment of secondary causes can prevent disease progression to fibrosis and cirrhosis.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

